Alzheimer's Disease and Immunotherapy

被引:0
作者
Madeo, Jennifer [1 ]
Frieri, Marianne [1 ]
机构
[1] Nassau Univ, Med Ctr, Dept Med, E Meadow, NY 11554 USA
来源
AGING AND DISEASE | 2013年 / 4卷 / 04期
关键词
Alzheimer's disease; immunotherapy; immunosenescence; vaccination; monoclonal antibodies; AMYLOID-BETA IMMUNOTHERAPY; CENTRAL-NERVOUS-SYSTEM; A-BETA; COGNITIVE IMPAIRMENT; MOUSE MODEL; PASSIVE IMMUNOTHERAPY; TRANSGENIC MOUSE; CLINICAL-TRIALS; DOUBLE-BLIND; MEMORY LOSS;
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is a growing health care epidemic. It is the most common cause of dementia and its incidence is rising. Age, which influences the oxidative and inflammatory states of the brain, is the most important risk factor. Currently there is no disease modifying treatments available for this irreversible, progressive debilitating disease. Immunotherapy represents an emerging, potentially disease modifying strategy aimed at reducing the pathological lesions of AD and facilitating cognitive improvement. Many clinical trials are currently underway. This literature review highlights current knowledge regarding the physiology of aging and how it relates to the pathogenesis of AD. In addition, immunotherapy is discussed in the context of its mechanism, current studies and future goals.
引用
收藏
页码:210 / 220
页数:11
相关论文
共 89 条
[1]   PASSIVE IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE: WHAT HAVE WE LEARNED, AND WHERE ARE WE HEADED? [J].
Aisen, P. S. ;
Vellas, B. .
JOURNAL OF NUTRITION HEALTH & AGING, 2013, 17 (01) :49-50
[2]  
Alonso-Fernandez Patricia, 2011, Curr Aging Sci, V4, P78
[3]   Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders [J].
Banks, WA .
JOURNAL OF NEUROVIROLOGY, 1999, 5 (06) :538-555
[4]   Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].
Bard, F ;
Cannon, C ;
Barbour, R ;
Burke, RL ;
Games, D ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Lieberburg, I ;
Motter, R ;
Nguyen, M ;
Soriano, F ;
Vasquez, N ;
Weiss, K ;
Welch, B ;
Seubert, P ;
Schenk, D ;
Yednock, T .
NATURE MEDICINE, 2000, 6 (08) :916-919
[5]   Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology [J].
Bard, F ;
Barbour, R ;
Cannon, C ;
Carretto, R ;
Fox, M ;
Games, D ;
Guido, T ;
Hoenow, K ;
Hu, K ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, C ;
Lee, M ;
Motter, R ;
Nguyen, M ;
Reed, A ;
Schenk, D ;
Tang, P ;
Vasquez, N ;
Seubert, P ;
Yednock, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :2023-2028
[6]   Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease [J].
Bateman, Randall J. ;
Xiong, Chengjie ;
Benzinger, Tammie L. S. ;
Fagan, Anne M. ;
Goate, Alison ;
Fox, Nick C. ;
Marcus, Daniel S. ;
Cairns, Nigel J. ;
Xie, Xianyun ;
Blazey, Tyler M. ;
Holtzman, David M. ;
Santacruz, Anna ;
Buckles, Virginia ;
Oliver, Angela ;
Moulder, Krista ;
Aisen, Paul S. ;
Ghetti, Bernardino ;
Klunk, William E. ;
McDade, Eric ;
Martins, Ralph N. ;
Masters, Colin L. ;
Mayeux, Richard ;
Ringman, John M. ;
Rossor, Martin N. ;
Schofield, Peter R. ;
Sperling, Reisa A. ;
Salloway, Stephen ;
Morris, John C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) :795-804
[7]   Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD [J].
Bayer, AJ ;
Bullock, R ;
Jones, RW ;
Wilkinson, D ;
Paterson, KR ;
Jenkins, L ;
Millais, SB ;
Donoghue, S .
NEUROLOGY, 2005, 64 (01) :94-101
[8]   Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease [J].
Blennow, Kaj ;
Zetterberg, Henrik ;
Rinne, Juha O. ;
Salloway, Stephen ;
Wei, Jenny ;
Black, Ronald ;
Grundman, Michael ;
Liu, Enchi .
ARCHIVES OF NEUROLOGY, 2012, 69 (08) :1002-1010
[9]   Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice [J].
Buchanan, J. B. ;
Sparkman, N. L. ;
Chen, J. ;
Johnson, R. W. .
PSYCHONEUROENDOCRINOLOGY, 2008, 33 (06) :755-765
[10]   Loss of Interleukin Receptor-Associated Kinase 4 Signaling Suppresses Amyloid Pathology and Alters Microglial Phenotype in a Mouse Model of Alzheimer's Disease [J].
Cameron, Brent ;
Tse, Wayne ;
Lamb, Raza ;
Li, Xiaoxia ;
Lamb, Bruce T. ;
Landreth, Gary E. .
JOURNAL OF NEUROSCIENCE, 2012, 32 (43) :15112-15123